Drug ID: | NPD2355 |
Drug Name: | |
Molecular Formula: | C17H15ClO4 |
Canonical SMILES: | Clc1ccc(cc1)C(=O)c1ccc(cc1)OC(C(=O)[O-])(C)C |
Standard InCHI: | InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21)/p-1 |
Standard InCHIKey: | MQOBSOSZFYZQOK-UHFFFAOYSA-M |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002936 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 11350701 |
ChEBI | |
CAS Number |
Molecular Weight | 317.06 |
ALogP | 0.0029 |
MLogP | 2.78 |
XLogP | 3.6 |
HDA | 3 |
HBD | 0 |
Rotatable Bonds | 9 |
TPSA | 66.43 |
RO5 Violation | 0 |